(Q44912433)

English

Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study

scientific article

Statements

Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study (English)
0 references
0 references
0 references
Veli Kairisto
Arnon Nagler
Johan Lanng Nielsen
Ugur Ozbek
Fausto Palmieri
Domenico Russo
Ole Weiss-Bjerrum
Bengt Simonsson
4 March 2009
4497-4504

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit